As of close of business last night, CareMax Inc.’s stock clocked out at $4.19, down -7.10% from its previous closing price of $4.51. In other words, the price has decreased by -$0.3200 from its previous closing price. On the day, 1499488 shares were traded. CMAX stock price reached its highest trading level at $4.6000 during the session, while it also had its lowest trading level at $4.1300.
To gain a deeper understanding of CMAX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.80 and its Current Ratio is at 4.80. In the meantime, Its Debt-to-Equity ratio is 0.39 whereas as Long-Term Debt/Eq ratio is at 0.39.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on September 07, 2022, initiated with a Hold rating and assigned the stock a target price of $7.50.
On January 07, 2022, UBS started tracking the stock assigning a Buy rating and target price of $14.
On October 20, 2021, Jefferies started tracking the stock assigning a Buy rating and target price of $15.Jefferies initiated its Buy rating on October 20, 2021, with a $15 target price.
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.86 while its Price-to-Book (P/B) ratio in mrq is 0.78.
Stock Price History:
Over the past 52 weeks, CMAX has reached a high of $9.23, while it has fallen to a 52-week low of $2.77. The 50-Day Moving Average of the stock is 3.9295, while the 200-Day Moving Average is calculated to be 5.6751.
It appears that CMAX traded 500.26K shares on average per day over the past three months and 787.81k shares per day over the past ten days. A total of 87.41M shares are outstanding, with a floating share count of 74.08M. Insiders hold about 0.20% of the company’s shares, while institutions hold 57.10% stake in the company. Shares short for CMAX as of Oct 13, 2022 were 3.86M with a Short Ratio of 4.65M, compared to 3.87M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 4.42% and a Short% of Float of 6.30%.
As of right now, 5 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.06 for the current quarter, with a high estimate of -$0.01 and a low estimate of -$0.12, while EPS last year was -$0.03. The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.02 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.05 and -$0.49 for the fiscal current year, implying an average EPS of -$0.36. EPS for the following year is -$0.11, with 5 analysts recommending between $0.49 and -$0.4.
A total of 6 analysts have provided revenue estimates for CMAX’s current fiscal year. The highest revenue estimate was $612M, while the lowest revenue estimate was $589.58M, resulting in an average revenue estimate of $595.05M. In the same quarter a year ago, actual revenue was $295.76M, up 101.20% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $739.23M in the next fiscal year. The high estimate is $816M and the low estimate is $630M. The average revenue growth estimate for next year is up 24.20% from the average revenue estimate for this year.